316 related articles for article (PubMed ID: 24924428)
1. Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages.
Watari K; Shibata T; Kawahara A; Sata K; Nabeshima H; Shinoda A; Abe H; Azuma K; Murakami Y; Izumi H; Takahashi T; Kage M; Kuwano M; Ono M
PLoS One; 2014; 9(6):e99568. PubMed ID: 24924428
[TBL] [Abstract][Full Text] [Related]
2. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages.
Jung JI; Cho HJ; Jung YJ; Kwon SH; Her S; Choi SS; Shin SH; Lee KW; Park JH
Int J Cancer; 2015 Jan; 136(2):258-70. PubMed ID: 24844408
[TBL] [Abstract][Full Text] [Related]
3. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model.
Cho HJ; Jung JI; Lim DY; Kwon GT; Her S; Park JH; Park JH
Breast Cancer Res; 2012 May; 14(3):R81. PubMed ID: 22616919
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
7. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
Hwang-Bo J; Bae MG; Park JH; Chung IS
BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
[TBL] [Abstract][Full Text] [Related]
8. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
10. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract][Full Text] [Related]
11. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
Kimura Y; Sumiyoshi M
Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and Antimetastatic Activity of Synthetic Hydroxystilbenes Through Inhibition of Lymphangiogenesis and M2 Macrophage Differentiation of Tumor-associated Macrophages.
Kimura Y; Sumiyoshi M; Baba K
Anticancer Res; 2016 Jan; 36(1):137-48. PubMed ID: 26722037
[TBL] [Abstract][Full Text] [Related]
14. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
[TBL] [Abstract][Full Text] [Related]
16. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
Cao R; Ji H; Feng N; Zhang Y; Yang X; Andersson P; Sun Y; Tritsaris K; Hansen AJ; Dissing S; Cao Y
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15894-9. PubMed ID: 22967508
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
20. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.
Watari K; Nakao S; Fotovati A; Basaki Y; Hosoi F; Bereczky B; Higuchi R; Miyamoto T; Kuwano M; Ono M
Biochem Biophys Res Commun; 2008 Dec; 377(3):826-31. PubMed ID: 18951870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
